Skip to main content

Advertisement

ADVERTISEMENT

videos

Kenneth Anderson, MD, Dana-Farber Cancer Institute
Videos
11/01/2023
At the 2023 Lymphoma, Leukemia & Myeloma Congress, Kenneth C. Anderson, MD, discussed existing and promising novel therapies for patients with multiple myeloma.
At the 2023 Lymphoma, Leukemia & Myeloma Congress, Kenneth C. Anderson, MD, discussed existing and promising novel therapies for patients with multiple myeloma.
At the 2023 Lymphoma, Leukemia &...
11/01/2023
Lymphoma, Leukemia & Myeloma Network
Kenneth Anderson, MD, Dana-Farber Cancer Institute
Videos
11/01/2023
At the 2023 Lymphoma, Leukemia & Myeloma Congress, Kenneth C. Anderson, MD, discussed existing and promising novel therapies for patients with multiple myeloma.
At the 2023 Lymphoma, Leukemia & Myeloma Congress, Kenneth C. Anderson, MD, discussed existing and promising novel therapies for patients with multiple myeloma.
At the 2023 Lymphoma, Leukemia &...
11/01/2023
Lymphoma, Leukemia & Myeloma Network
Eric Padron, MD, Moffitt Cancer Center
Videos
10/24/2023
During the 2023 Lymphoma, Leukemia & Myeloma Congress in New York, Eric Padron, MD, discusses updates regarding managing and treating chronic myelomonocytic leukemia.
During the 2023 Lymphoma, Leukemia & Myeloma Congress in New York, Eric Padron, MD, discusses updates regarding managing and treating chronic myelomonocytic leukemia.
During the 2023 Lymphoma,...
10/24/2023
Lymphoma, Leukemia & Myeloma Network
Eric Padron, MD, Moffitt Cancer Center
Videos
10/24/2023
During the 2023 Lymphoma, Leukemia & Myeloma Congress in New York, Eric Padron, MD, discusses updates regarding managing and treating chronic myelomonocytic leukemia.
During the 2023 Lymphoma, Leukemia & Myeloma Congress in New York, Eric Padron, MD, discusses updates regarding managing and treating chronic myelomonocytic leukemia.
During the 2023 Lymphoma,...
10/24/2023
Lymphoma, Leukemia & Myeloma Network
Julie Vose, MD
Videos
10/24/2023
At the Lymphoma, Leukemia & Myeloma Congress in New York, New York, Julie Vose, MD, discusses advances in improving outcomes for patients with peripheral T-cell lymphoma.
At the Lymphoma, Leukemia & Myeloma Congress in New York, New York, Julie Vose, MD, discusses advances in improving outcomes for patients with peripheral T-cell lymphoma.
At the Lymphoma, Leukemia &...
10/24/2023
Lymphoma, Leukemia & Myeloma Network
Julie Vose, MD
Videos
10/24/2023
At the Lymphoma, Leukemia & Myeloma Congress in New York, New York, Julie Vose, MD, discusses advances in improving outcomes for patients with peripheral T-cell lymphoma.
At the Lymphoma, Leukemia & Myeloma Congress in New York, New York, Julie Vose, MD, discusses advances in improving outcomes for patients with peripheral T-cell lymphoma.
At the Lymphoma, Leukemia &...
10/24/2023
Lymphoma, Leukemia & Myeloma Network
Amer M. Zeidan, MBBS, MHS, Yale
Videos
10/24/2023
During the 2023 Lymphoma, Leukemia & Myeloma Congress in New York, Amer Zeidan, MBBS, MHS, provided insights into novel treatment updates for patients with high and low-risk MDS.
During the 2023 Lymphoma, Leukemia & Myeloma Congress in New York, Amer Zeidan, MBBS, MHS, provided insights into novel treatment updates for patients with high and low-risk MDS.
During the 2023 Lymphoma,...
10/24/2023
Oncology
Amer M. Zeidan, MBBS, MHS, Yale
Videos
10/24/2023
During the 2023 Lymphoma, Leukemia & Myeloma Congress in New York, Amer Zeidan, MBBS, MHS, provided insights into novel treatment updates for patients with high and low-risk MDS.
During the 2023 Lymphoma, Leukemia & Myeloma Congress in New York, Amer Zeidan, MBBS, MHS, provided insights into novel treatment updates for patients with high and low-risk MDS.
During the 2023 Lymphoma,...
10/24/2023
Oncology
Koen van Besien, MD
Videos
03/13/2023
Koen W. van Besien, MD, recaps a debate in which he argued that patients with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) and TP53 mutations should undergo allogeneic stem cell transplantation.
Koen W. van Besien, MD, recaps a debate in which he argued that patients with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) and TP53 mutations should undergo allogeneic stem cell transplantation.
Koen W. van Besien, MD, recaps a...
03/13/2023
Oncology
Sundar Jagannath, MD, Mount Sinai
Videos
02/23/2023
Sundar Jagannath, MD, provides an update on how immunotherapy and cellular therapy are changing treatment approaches for multiple myeloma.
Sundar Jagannath, MD, provides an update on how immunotherapy and cellular therapy are changing treatment approaches for multiple myeloma.
Sundar Jagannath, MD, provides...
02/23/2023
Oncology

Advertisement